
    
      Investigator hypothesize that low dose peri-operative topiramate is superior to gabapentin in
      reducing postoperative pain and opioid consumption after primary TJA with a more favorable
      side effect profile that will facilitate patient optimization via pre- and postoperative
      weight loss.
    
  